| Name | Hyde Pharmacy |
|---|---|
| Organization Name | Hyde Pharmacy Inc |
| Location | 1001 W Kingshighway, Paragould, Arkansas 72450 |
| Type | Long Term Care Pharmacy |
| Phone | (870) 239-4036 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The incidence of eating disorders was found to be 2.3-fold higher among Muslim adolescents than among their Christian classmates. Similarly, body dissatisfaction was 1.8-fold higher in the former group.
Vanguard Health Systems, Inc. announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the "Issuers"), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
› Verified 9 days ago
| NPI Number | 1396526661 |
| Organization Name | HYDE PHARMACY INC |
| Doing Business As | HYDE PHARMACY LTC |
| Type | Long Term Care Pharmacy |
| Address | 1001 W Kingshighway, Paragould, AR 72450 |
| Phone Number | 870-239-4036 |
News Archive
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The incidence of eating disorders was found to be 2.3-fold higher among Muslim adolescents than among their Christian classmates. Similarly, body dissatisfaction was 1.8-fold higher in the former group.
Vanguard Health Systems, Inc. announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the "Issuers"), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
› Verified 9 days ago
| NPI Number | 1487675310 |
| Organization Name | HYDE PHARMACY INC |
| Type | Community/Retail Pharmacy |
| Address | 1001 W Kingshighway, Paragould, AR 72450 |
| Phone Number | 870-239-4036 |
News Archive
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The incidence of eating disorders was found to be 2.3-fold higher among Muslim adolescents than among their Christian classmates. Similarly, body dissatisfaction was 1.8-fold higher in the former group.
Vanguard Health Systems, Inc. announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the "Issuers"), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
› Verified 9 days ago
| NPI Number | 1538597752 |
| Organization Name | HYDE PHARMACY INC (IMMUNIZATION) |
| Type | Community/Retail Pharmacy |
| Address | 1001 W Kingshighway, Paragould, AR 72450 |
| Phone Number | 870-239-4036 |
News Archive
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The incidence of eating disorders was found to be 2.3-fold higher among Muslim adolescents than among their Christian classmates. Similarly, body dissatisfaction was 1.8-fold higher in the former group.
Vanguard Health Systems, Inc. announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the "Issuers"), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
› Verified 9 days ago
News Archive
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The incidence of eating disorders was found to be 2.3-fold higher among Muslim adolescents than among their Christian classmates. Similarly, body dissatisfaction was 1.8-fold higher in the former group.
Vanguard Health Systems, Inc. announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the "Issuers"), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019.
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states.
› Verified 9 days ago
Affordable Medical Type: DME Supplier - Oxygen Equipment & Supplies Location: 501 W Kingshighway, Paragould, Arkansas 72450 Phone: (870) 239-0997 | |
Cvs Pharmacy #10678 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1501 W Kings Hwy, Paragould, Arkansas 72450 Phone: (870) 240-8405 | |
Harris Eye Clinic Type: Medicare Supplier Location: 901 Linwood Dr, Paragould, Arkansas 72450 Phone: (870) 239-2251 | |
Walden Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3104 W Kingshighway, Paragould, Arkansas 72450 Phone: (870) 236-6118 | |
Hyde Pharmacy Type: Long Term Care Pharmacy Location: 1001 W Kingshighway, Paragould, Arkansas 72450 Phone: (870) 239-4036 |